Roivant Sciences Ltd.

Ownership Transactions Reported by 25 Insiders

	Insiders	Shares	%	Avg Price	Total $
Buys	1	+3.32K	0%	$15.07	+$50K
Sells	4	-12M	100%	$12.30	-$148M
Net	-3	-12M	-99.9%		-$148M

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Dexcel Pharma Technologies Ltd.	10%+ Owner	$1.06B			Nov 10, 2022
SVF Investments (UK) Ltd	10%+ Owner	$756M			Sep 28, 2023
Sumitomo Chemical Co., Ltd.	10%+ Owner	$737M			Jun 22, 2023
Vivek Ramaswamy	10%+ Owner	$620M	-$54.1M	-8.03%	Sep 3, 2025
Daniel Gold	Director	$443M			Sep 10, 2025
Keith Manchester	Director	$344M			Sep 10, 2025
QVT Financial LP	Director by Deputization	$323M			Jun 25, 2025
Matthew Gline	CEO, Director	$261M	+$50K	+0.02%	Sep 18, 2025
Mayukh Sukhatme	Pres&Chief Investment Officer, Director	$226M	-$15.6M	-6.46%	Dec 23, 2024
Frank Torti	President and Vant Chair	$151M			Jul 30, 2025
Viking Global Performance Llc	10%+ Owner	$133M			Jun 22, 2023
Viking Global Investors Lp	10%+ Owner	$133M			Jun 22, 2023
Eric Venker	President & Immunovant CEO	$24.4M	-$75.6M	-75.6%	Oct 6, 2025
Benjamin Zimmer	President, Roivant Health	$12.1M			Oct 1, 2021
Richard Pulik	Cfo	$5.91M			Sep 28, 2025
Rakhi Kumar	Chief Accounting Officer	$1.74M	-$2.37M	-57.7%	Feb 20, 2025
Jennifer Humes	Chief Accounting Officer	$1.23M			Mar 20, 2025
Ilan Oren	Director	$1.22M			Sep 10, 2025
James C. Momtazee	Director	$1.13M			Sep 10, 2025
Meghan Fitzgerald	Director	$592K			Sep 10, 2025
Andrew Lo	Director	$540K			Sep 15, 2022
Melissa Epperly	Director	$472K			Sep 10, 2025
Hiroshi Nomura	Director				Sep 16, 2022
Masayo Tada	Director				Oct 1, 2021
Patrick Machado	Director				Oct 1, 2021

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.